Resveratrol and Metabolic Health: Latest Evidence

⚠️ IMPORTANT LEGAL NOTICE

These scientific studies are for informational purposes only.

The presented research results are NOT approved Health Claims under EU Regulation (EC) No 1924/2006. Only Health Claims officially approved by EFSA may be used for product advertising.

Non-approved Health Claims are legally impermissible and may lead to warnings.

✅ Check approved claims: [EU Health Claims Register](https://ec.europa.eu/food/safety/labelling_nutrition/claims/register/public/)

---

## Summary

A systematic review by Li Y et al. from 2023 investigates the metabolic effects of resveratrol and was published in Phytomedicine.

Study Background

This systematic review analyzes the effects of resveratrol on blood glucose, lipid profile, and insulin sensitivity.

Key Findings

The study shows: - Improvement of insulin sensitivity: Reduction in HOMA-IR - Lipid profile: LDL cholesterol reduced by 10-15% - Dosage: 150-500 mg daily - Bioavailability: Micronization improves absorption

Methodology

As a systematic review, this work combines findings from 25 clinical studies with over 1500 participants.

Practical Relevance for Dietary Supplement Manufacturers

These research results are relevant for: - Product development: Micronized or liposomal formulations - Study results: The research shows certain effects (no approved claims) - Dosage: 150-500 mg per day - Source: Prefer trans-resveratrol

Source

The full study is freely available on Europe PMC.

Authors: Li Y, Liu M, Wang Y, Zhang Q, Liu Z, Shi R Year: 2023 Journal: Phytomedicine PMCID: PMC10274420 PMID: 37329809

---

*Note: This summary is for informational purposes. The presented study results are not approved Health Claims. For detailed information, please consult the original source.*